mass spectrometry comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
| Property | Value | Notes |
|---|---|---|
| Purity determination | Reversed-phase HPLC | UV detection commonly at 214 nm |
| Mass confirmation | Mass spectrometry | Compared against theoretical 888.5 Da |
| Powder storage | -20 C or below | Dry and protected from light |
| Reconstituted storage | Aliquoted and frozen | Avoid repeated freeze-thaw cycles |
| Reconstitution solvent | Sterile water or neutral buffer | Avoid extreme pH conditions |
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Die Harnblase ist ein Hohlorgan, das beim Menschen auf dem Beckenboden aufliegt. Es befindet sich direkt hinter der Schambeinfuge, vor der Vagina bei Frauen bzw. dem Mastdarm bei Männern, wobei es bei Frauen etwas kaudaler (niedriger) liegt. Nach oben erstreckt sich die Harnblase bis zur Oberkante des Beckens. Mit zunehmender Füllung kann sie bis zum Bauchnabel reichen. Ihre Vorderseite heißt Apex, der Raum zwischen Schambein und Blasenvorderwand (Spatium retropubicum) „Cavum Retzii“; die posteroinferiore (untere hintere) Seite Fundus. Der Blasenhals (die Cervix vesicae) befindet sich bei Primaten (und damit auch beim Menschen) auf der Unterseite, bei anderen Tieren an der Hinterseite und führt zur Harnröhre. Die Harnblase empfängt auf ihrer hinteren unteren Seite die paarigen Harnleiter (Ureter) von den beiden Nieren. Die Harnleiter verlaufen über eine kurze Distanz innerhalb der Blasenwand, so dass sie bei stärkerer Füllung der Harnblase abknicken, so dass der Rückfluss (physiologisch generell) verhindert wird. Außerdem werden die Ureter durch die Kontraktion der glatten Muskulatur in der Blasenwand beim Harnlassen zusammengedrückt. Dies wirkt ebenso dem Rückfließen des Urins entgegen. Das Trigonum vesicae ist die dreieckige Fläche, die von Eingängen der beiden Harnleiter und vom Ausgang der Harnröhre gebildet wird. Das Trigonum vesicae dient außerdem bei einer endoskopischen Untersuchung dem Arzt als Orientierung zum schnelleren Auffinden der Uretermündungen. Die Harnblase besitzt an ihrem Ausgang zwei Schließmuskeln (Blasensphinkter), einen inneren und einen äußeren.
Der innere besteht aus glatter Muskulatur und unterliegt der Kontrolle des vegetativen Nervensystems, was bedeutet, dass er nicht willentlich gesteuert werden kann. Der äußere Schließmuskel Musculus urethralis ist ein ringförmiger Skelettmuskel, der bewusst gesteuert werden kann. Neben der Einbettung der Harnröhre in den Beckenboden wird die Harnblase über drei Bauchfellfalten (Serosa-Duplikaturen) befestigt. Von der Seitenwand der Harnblase zieht beidseits ein seitliches Harnblasenband (Ligamentum vesicae laterale), von der Bauchseite das mittlere Harnblasenband (Ligamentum vesicae medianum) zur Innenwand der Bauchhöhle. Das mediane (mittlere) Band ist ein Überbleibsel des Urachus. In den seitlichen Harnblasenbändern verläuft jeweils ein rundlicher Strang, das runde Harnblasenband (Ligamentum teres vesicae), das den Überrest der verschlossenen Nabelarterie (Arteria umbilicalis) darstellt. Alle drei Bänder laufen nach dem Verlassen des kleinen Beckens als Teil des Peritoneum parietale anterior zum Bauchnabel.
=== Blutversorgung === Die Blutversorgung der Harnblase erfolgt durch die Arteriae vesicales superiores (obere Blasenarterien, bei Tieren ist dies die vordere Blasenarterie Arteria vesicalis cranialis), einer Fortführung der Nabelarterie (Arteria umbilicalis), die ihrerseits aus der Arteria iliaca interna entspringt. Weiterhin wird sie durch die Arteria vesicalis inferior (untere Blasenarterie, bei Tieren ist dies die hintere Blasenarterie Arteria vesicalis caudalis), einen Ast der Arteria iliaca interna versorgt. Bei Frauen gelangt auch Blut von der Arteria vaginalis (Scheidenarterie), einem Ast der Arteria uterina (Gebärmutterarterie) zur Harnblase. Der Blutabfluss erfolgt durch den Plexus venosus vesicalis (Blasenvenengeflecht), bei Männern auch durch den Plexus venosus prostaticus (Venengeflecht der Prostata), die in die Vena iliaca interna münden.
=== Innervation === Die funktionelle Innervation der Harnblase erfolgt durch das vegetative Nervensystem. Dieses unterliegt nicht der bewussten Kontrolle und wird deshalb auch autonomes Nervensystem genannt. Man unterscheidet zwei Anteile: den Sympathikus, der in Stress-, Angriffs- und Fluchtsituationen aktiv wird, und den Parasympathikus, der in Ruhesituationen aktiv wird und der Regeneration und dem Aufbau körpereigener Reserven dient. Die sympathische Innervation erfolgt durch Nerven vom Plexus vesicalis et prostaticus, die mit dem Nervus hypogastricus in Verbindung stehen. Sie entspannen den Detrusormuskel und kontrahieren den inneren Schließmuskel. Dies verhindert unwillkürliches Harnlassen. Die parasympathische Innervation erfolgt durch Nerven, die im sakralen Teil des Rückenmarks (S2–S4) ihren Ursprung nehmen. Sie verursachen die Kontraktion des Detrusormuskels (s. u.) und die Entspannung des inneren Schließmuskels und leiten somit das Harnlassen (Miktion) ein. Die Innervation des Musculus urethralis erfolgt durch die Nervi perineales (Dammnerven), Äste des Nervus pudendus (Schamnerv).
Sources: de.wikipedia.org
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.
Mass spectrometry is the usual confirmatory method because it measures the intact mass. Reversed-phase chromatography is used alongside it to estimate purity.
Not directly. Reported percentages depend on the chromatographic method, detection wavelength, and integration criteria, so the underlying method details matter.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.